ARCHIVES

DCT’s Experimental Therapeutic Program Outlined to Board

This article is from The Cancer Letter archive.

Vol. 01 No. 18 | May 2, 1975

Download PDF Visit The Full Archive

Related Articles

DCPC Board approves New CCOP RFA Following Addition Of Public Health, Education Components

May 16, 1986

Zevalin Regimen Effective In Mantle Cell Lymphoma

January 30, 2004

Implantable Drug Delivery Device Offers Better Pain Relief

September 27, 2002

In Brief: Cooper Says HEW May Stop Taking New Construction grants; Cancer Act Does Not Give Him That Right

May 2, 1975

Carcinogenesis Program Direction Changes Near for Extramural research; Workshop Topics Listed

April 22, 1977

Trading In Stock Of U.S. Bioscience Halted, Newsletter Report Cited

October 9, 1992